Challenges and potential solutions to enrollment in a clinical trial of arteriovenous fistula vs arteriovenous graft vascular access strategy

By sjmartinez • January 13, 2025

Goldman MP, Patel DM, Chang KZ, Davis RP, Edwards MS, Hurie JB, Sutsrim A, Velazquez-Ramirez G, Williams TK, Grandas OH, Freeman MB, McNally MM, Stevens SL, Bennett KM, Woo K, Carsten CG, Androes MP, Blas JV, Jones B, Patton RM, Parr R, Gandhi SS, York JW, Young CJ, Rabbani MU, Gardezi AI, Abdelnour LM, Lee T, Abusalah WM, Zayas CF, Hicks CW, Geetha D, Brown WM, Chen H, Allon M, Murea M; AV Access Consortium. Challenges and potential solutions to enrollment in a clinical trial of arteriovenous fistula vs arteriovenous graft vascular access strategy. JVS Vasc Insights. 2024;2:100108. doi: 10.1016/j.jvsvi.2024.100108. Epub 2024 Jun 7. PMID: 39802461; PMCID: PMC11720168.

Tags: Arteriovenous fistula, Arteriovenous graft, Hemodialysis vascular access, Nephrology, Publications, Randomized Controlled Trial

Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis

Heerspink HJL, Beernink JM, Agarwal R, Cherney DZI, Lam CSP, Neuen BL, Perkovic V, Tuttle KR, Sarafidis P, Birne R, Chen X, Hornum M, Maldonado[...]

Correction of Alkalemia in a Hemodialysis Patient: A Case Report

Luu YH, Hajmomenian HR, Khorsan R. Correction of Alkalemia in a Hemodialysis Patient: A Case Report. Cureus. 2026 Jul 28;18(7):e113556. doi: 10.7759/cureus.113556. PMID: 42666655; PMCID:[...]

Favorable Adherence and Tolerability of Letermovir Versus Valganciclovir for Cytomegalovirus Prophylaxis in Kidney Transplant Recipients Aged 65 y or Older: Findings From a Randomized, Phase 3 Trial

Bunnapradist S, Vincenti F, Witzke O, Schneeberger S, Nguyen MH, Broyde N, Gilbert CL, Haber B. Favorable Adherence and Tolerability of Letermovir Versus Valganciclovir for[...]